Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-14 Tax Withholding | 2024-11-18 4:29 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.92 | 16,961 (Direct) | View |
| 2024-08-14 Tax Withholding | 2024-08-16 4:50 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $7.02 | 17,363 (Direct) | View |
| 2024-05-14 Tax Withholding | 2024-05-16 6:58 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 402 | $8.36 | 17,765 (Direct) | View |
| 2024-02-14 Tax Withholding | 2024-02-16 5:10 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Development Officer | 468 | $3.4 | 18,167 (Direct) | View |
| 2023-11-14 Tax Withholding | 2023-11-16 7:41 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer | 1,395 | $5.08 | 18,635 (Direct) | View |
| 2022-11-14 Option Award | 2022-11-16 7:21 pm | N/A 2032-11-13 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer | 80,120 | $0 | 80,120 (Direct) | View |
Ownership | 2022-11-09 8:30 pm | N/A 2031-03-24 | Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer | 0 | $0 | 162,206 (Direct) | View |